US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.42

+0.05000.15%

Volume:18.03K

Turnover:618.46K

Market Cap:106.70M

PE:- -

High:34.53

Open:34.53

Low:34.07

Close:34.37

52wk High:36.84

52wk Low:25.00

Shares:3.10M

Float Shares:3.10M

Volume Ratio:0.59

T/O Rate:0.58%

Dividend:0.39

Dividend Rate:1.14%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee

Nurix Extends Gilead Collaboration for Oncology Program

CSPC Pharma to Unveil Eight New Clinical Trial Advances at 2026 ESMO Congress

Nurix - Eligible for up to $1.30 Bln in Total Payments as of May 31, 2026

THOMSON REUTERS

Nurix - Eligible for Mid-Single-Digit to Low-Teens Percentage Tiered Royalties

THOMSON REUTERS

Nurix - to Receive $10 Mln Research Term Extension Fee

THOMSON REUTERS

Nurix - Retains Co-Development and 50/50 Profit Sharing Options on Two U.S. Programs

THOMSON REUTERS

Gilead CEO Daniel O’Day Disposes of USD 2,216,507.50 in Common Shares

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says

MT Newswires Live

Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise

Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)

Piper Sandler Remains a Buy on Regeneron (REGN)

Major Drugmakers Turn to China for Licensing Deals

Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals

Analysts’ Top Healthcare Picks: Regeneron (REGN), Idexx Laboratories (IDXX)

Vertex Minerals lodges 2026 corporate governance statement with ASX

Sino Biopharmaceutical Stock Falls 2.3% in Hong Kong, Underperforms Competitors

Hong Kong Stock Movers: Innovative Drug Stocks Retreat, InnoCare Pharma (09969) Falls Over 8%, RemeGen (09995) Drops Nearly 6%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/IBBQ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.42,"timestamp":1791215901082,"preClose":34.37,"halted":0,"volume":18029,"delay":0,"changeRate":0.0014547570555718437,"floatShares":3100001,"shares":3100001,"eps":0,"marketStatus":"Trading","change":0.05,"latestTime":"10-05 12:05:08 EDT","open":34.53,"high":34.53,"low":34.07,"amount":618462.30875,"amplitude":0.013384,"askPrice":34.43,"askSize":3300,"bidPrice":34.39,"bidSize":700,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791230400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":34.37,"sharesOutstanding":2520001,"nav":34.4248,"aum":106440372.14,"dividendRate":0.011383,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":34.37,"preClose":34.37,"latestTime":"07:35 EDT","volume":1,"amount":34.37,"timestamp":1791200149459,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":34.37,"preClose":34.37,"latestTime":"19:30 EDT","volume":23,"amount":793.71,"timestamp":1790983804820,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.592852,"impliedVol":0.0734,"impliedVolPercentile":0.2151},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":3100001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.592852,"shares":3100001,"dividePrice":0.3918,"high":34.53,"amplitude":0.013384,"preClose":34.37,"low":34.07,"week52Low":25,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.42,"committee":-0.65,"eps":0,"divideRate":0.011383,"volume":18029,"delay":0,"ttmEps":0,"open":34.53,"prevYearClose":28.3962,"prevWeekClose":34.37,"prevMonthClose":35.14,"prevQuarterClose":35.14,"fiveDayClose":35.28,"twentyDayClose":36.05,"sixtyDayClose":33.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"IBBQ","amount":0.23037,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673704303","title":"Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704303","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704303?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:03","pubTimestamp":1791198202,"startTime":"0","endTime":"0","summary":"Nurix, Gilead extend research term for oncology program by two years for $10 million feeNurix Therapeutics extended the research term for an undisclosed oncology program under its strategic collaborat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL7nTmpm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","SG9999015986.USD","LU0109394709.USD","LU0320765992.SGD","IE00B3T34201.USD","LU0965509283.SGD","SG9999015978.USD","BBH","LU0965509010.AUD","LU0965509101.SGD","LU1066051498.USD","IE00BN0W2W23.USD","IE00BQXX3D17.EUR","IBBQ","BK4566","MEDI","GILD","LU1037948897.HKD","LU1934455194.USD","SG9999015945.SGD","BIB","BK4568","IE00BZ1G4Q59.USD","BMED","LU0058720904.USD","LU1037948541.HKD","LU2210150020.SGD","SG9999014021.USD","IBB","LU2087621335.USD","BK4585","BK4578","IE00BQXX3F31.USD","LU2468319806.SGD","LU1430594728.SGD","LU1839511570.USD","LU0289739699.SGD","LU0859254822.USD","LU1057294990.SGD","LU1934455277.USD","TBXU","LU0314104364.USD","BK4583","LU0882574055.USD","BCDF","BK4112","NDAQ","TMED","LU0861579265.USD","NRIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704306","title":"Nurix Extends Gilead Collaboration for Oncology Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704306","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704306?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:03","pubTimestamp":1791198199,"startTime":"0","endTime":"0","summary":"BRIEF-Nurix Extends Gilead Collaboration For Oncology ProgramOct 5 (Reuters)-Nurix Therapeutics, Inc.NRIX.O:NURIX THERAPEUTICS ANNOUNCES SECOND RESEARCH TERM EXTENSION FOR ONCOLOGY PROGRAM UNDER COLLA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","LU1585245621.USD","IE00BSNM7G36.USD","LU0058720904.USD","LU0320765992.SGD","LU1037948897.HKD","LU1057294990.SGD","LU1934455863.HKD","LU2357627491.SGD","LU1066053197.SGD","TMED","LU0965509283.SGD","LU0965509101.SGD","SG9999015952.SGD","LU0861579265.USD","LU0965508806.USD","LU2468319806.SGD","SG9999015945.SGD","BIB","LU0965509010.AUD","LU1674673691.USD","LU0109394709.USD","MEDI","BK4566","TBXU","LU1571399168.USD","LU2324357040.USD","IE00B7SZLL34.SGD","BMED","BBH","IE00B3T34201.USD","LU1023059063.AUD","IBB","LU0859254822.USD","SG9999015978.USD","LU1839511570.USD","GILD","BK4139","IE00BKVL7J92.USD","LU2087621335.USD","IBBQ","IE00B19Z3B42.SGD","IE0002270589.USD","NRIX","LU2089984988.USD","LU1934455277.USD","BK4550","LU0122379950.USD","LU1934455194.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170526775","title":"CSPC Pharma to Unveil Eight New Clinical Trial Advances at 2026 ESMO Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=1170526775","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170526775?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198018,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that the group will present 8 latest clinical trial advances at the European Society for Medical Oncology (ESMO) Annual Congress, taking place in Madrid, Spain from...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287792.SGD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","LU2039709279.SGD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","KURE","IE0008368742.USD","IBBQ","SG9999004220.SGD","LU1993786604.SGD","HK0000165453.HKD","BK1515","LU1328277881.USD","LU1813983027.USD","LU1960683339.HKD","MDTX","LU0501845795.SGD","LU0880133367.SGD","PSYK","LU0314109678.HKD","BK1191","LU1226287529.USD","LU1226288170.HKD","LU0315179316.USD","LU1008478684.HKD","LU0326950275.SGD","LU1226287875.USD","IE00B031HY20.USD","LU0067412154.USD","LU1152091168.USD","IBBJ","LU1226288253.USD","LU0140636845.USD","LU1807302812.USD","LU0072913022.USD","LU1152091754.HKD","LU1951186391.HKD","BK1521","BMED","IE0008369823.USD","01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704828","title":"Nurix - Eligible for up to $1.30 Bln in Total Payments as of May 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704828","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673704828?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDI","IE00B3T34201.USD","BBH","LU1778281490.HKD","IE00BKVL7J92.USD","LU1066053197.SGD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","IBBQ","LU0965509283.SGD","LU1037948897.HKD","LU1023059063.AUD","BK4566","LU1585245621.USD","SG9999015978.USD","BMED","IBB","IE00BZ1G4Q59.USD","LU0823416689.USD","LU1061106388.HKD","LU1839511570.USD","BK4583","BK4139","BK4585","BK4532","LU0234570918.USD","LU0859254822.USD","LU1571399168.USD","LU2089984988.USD","LU0320765992.SGD","LU0058720904.USD","NRIX","LU1934455277.USD","IE00BSNM7G36.USD","LU0114720955.EUR","LU2112291526.USD","BK4578","LU2324357040.USD","LU0122379950.USD","LU1934455194.USD","BK4550","GILD","TMED","BK4588","LU0861579265.USD","LU0289739699.SGD","TBXU","BIB","BK4568","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673048487","title":"Nurix - Eligible for Mid-Single-Digit to Low-Teens Percentage Tiered Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2673048487","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673048487?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0002270589.USD","LU0122379950.USD","LU0965509101.SGD","BK4566","GILD","IE00B19Z3581.USD","TMED","TBXU","BMED","LU1037948897.HKD","LU0965509283.SGD","LU2089984988.USD","SG9999015986.USD","LU0889565916.HKD","LU0965509010.AUD","LU0320765992.SGD","LU0861579265.USD","LU1674673428.USD","SG9999015945.SGD","IE00BSNM7G36.USD","LU1066053197.SGD","LU0289739699.SGD","LU2087621335.USD","BK4568","MEDI","LU1037948541.HKD","BIB","IE00B3T34201.USD","LU1571399168.USD","IE00B19Z3B42.SGD","SG9999015952.SGD","IBB","LU1778281490.HKD","LU1839511570.USD","NRIX","LU1066051498.USD","LU0234570918.USD","BBH","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1057294990.SGD","BK4550","LU1934455194.USD","LU1934455863.HKD","LU2468319806.SGD","LU1430594728.SGD","LU0859254822.USD","LU1023059063.AUD","LU0823416689.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673048127","title":"Nurix - to Receive $10 Mln Research Term Extension Fee","url":"https://stock-news.laohu8.com/highlight/detail?id=2673048127","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673048127?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0965509010.AUD","LU0823416689.USD","IBB","LU1778281490.HKD","BK4566","LU1571399168.USD","LU1934455863.HKD","LU0320765992.SGD","LU1934455194.USD","LU1674673428.USD","SG9999015952.SGD","BMED","IE00BSNM7G36.USD","LU1430594728.SGD","TBXU","LU0965509101.SGD","BK4550","LU0965509283.SGD","LU0889565916.HKD","LU1037948541.HKD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","IE0002270589.USD","LU2468319806.SGD","IE00B19Z3581.USD","LU1057294990.SGD","LU1066053197.SGD","LU0122379950.USD","LU1066051498.USD","BIB","LU2087621335.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","IE00B3T34201.USD","TMED","NRIX","LU1023059063.AUD","SG9999015986.USD","LU1037948897.HKD","SG9999015945.SGD","BBH","GILD","MEDI","LU0289739699.SGD","LU0861579265.USD","LU0859254822.USD","LU2089984988.USD","IBBQ","BK4568","LU1839511570.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673021701","title":"Nurix - Retains Co-Development and 50/50 Profit Sharing Options on Two U.S. Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2673021701","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673021701?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:00","pubTimestamp":1791198000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nTUA7MVP3J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999015945.SGD","LU1934455194.USD","BK4578","LU1571399168.USD","LU0889565916.HKD","LU0859254822.USD","NRIX","TMED","BK4566","BBH","LU0320765992.SGD","LU0965509283.SGD","LU2468319806.SGD","BK4583","IE00B19Z3B42.SGD","LU0058720904.USD","LU1066053197.SGD","BK4532","LU1061106388.HKD","LU1057294990.SGD","LU0882574055.USD","LU1037948541.HKD","LU0861579265.USD","LU1066051498.USD","BIB","BMED","SG9999015986.USD","LU0122379950.USD","BK4568","LU1839511570.USD","IBB","LU1934455277.USD","TBXU","IBBQ","IE0002270589.USD","IE00BSNM7G36.USD","LU1778281490.HKD","GILD","IE00B3T34201.USD","LU2087621335.USD","BK4585","LU1430594728.SGD","LU0289739699.SGD","MEDI","LU0109394709.USD","IE00BZ1G4Q59.USD","LU1037948897.HKD","LU0965509010.AUD","SG9999015978.USD","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749473","title":"Gilead CEO Daniel O’Day Disposes of USD 2,216,507.50 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749473","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749473?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:42","pubTimestamp":1790973757,"startTime":"0","endTime":"0","summary":"Gilead CEO Daniel O’Day disposes of USD 2,216,507.50 in common sharesGilead Sciences Chairman and CEO Daniel Patrick O’Day sold 15,000 common shares on Oct. 1, 2026.Sales were priced at USD 147.719 an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL7B1xgm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead CEO Daniel O’Day Disposes of USD 2,216,507.50 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU0889565916.HKD","BMED","GILD","IE00B19Z3581.USD","LU1066051498.USD","IE0002270589.USD","LU1934455277.USD","BBH","BIB","LU1037948897.HKD","IE00BKVL7J92.USD","LU2357627491.SGD","LU2468319806.SGD","LU0823416689.USD","SG9999015986.USD","BK4578","LU1571399168.USD","SG9999015978.USD","LU2089984988.USD","TMED","LU1430594728.SGD","LU1934455194.USD","MEDI","BK4588","LU0320765992.SGD","LU0861579265.USD","LU1674673428.USD","BK4585","LU0109394709.USD","LU1023059063.AUD","BK4532","LU0058720904.USD","LU2087621335.USD","LU0114720955.EUR","LU0965509101.SGD","LU1585245621.USD","LU0289739699.SGD","LU1934455863.HKD","IBBQ","LU0234570918.USD","IE00B19Z3B42.SGD","LU0882574055.USD","BK4550","IE00BSNM7G36.USD","LU0859254822.USD","LU0965508806.USD","TBXU","LU1778281490.HKD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749136","title":"Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749136","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749136?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:35","pubTimestamp":1790973300,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 1.87% to $144.74 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.73% to 7,722.72 and the Dow Jones Industrial Average  rising 0.49% to 51,176.96.This was the stock's fourth consecutive day of losses.Gilead Sciences Inc. closed 7.98% below its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.02% to $256.03, Pfizer Inc.  fell 1.14% to $27.80, and Abbott Laboratories  rose 0.84% to $97.50.Trading volume  remained 1.3 million below its 50-day average volume of 6.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","LU0889565916.HKD","BMED","GILD","IE00B19Z3581.USD","BK4568","IE0002270589.USD","LU1066051498.USD","LU1934455277.USD","BBH","BIB","LU1037948897.HKD","IE00BKVL7J92.USD","LU2357627491.SGD","LU2468319806.SGD","LU0823416689.USD","SG9999015986.USD","SG9999015952.SGD","BK4578","IE00BZ1G4Q59.USD","LU1571399168.USD","LU1674673691.USD","LU2089984988.USD","SG9999015978.USD","TMED","LU0965509010.AUD","LU1430594728.SGD","LU1934455194.USD","MEDI","BK4588","IE00B7SZLL34.SGD","LU0320765992.SGD","LU0861579265.USD","LU1674673428.USD","BK4585","SG9999015945.SGD","BK4583","LU0109394709.USD","LU1023059063.AUD","LU1839511570.USD","LU1037948541.HKD","LU1057294990.SGD","BK4532","LU0058720904.USD","LU0122379950.USD","LU1061106388.HKD","LU0114720955.EUR","LU2087621335.USD","LU0965509101.SGD","LU1585245621.USD","LU0289739699.SGD","LU1934455863.HKD","IBBQ","LU0234570918.USD","IE00B19Z3B42.SGD","BK4139","BK4566","BK4550","IE00BSNM7G36.USD","IE00B3T34201.USD","LU0882574055.USD","LU0965509283.SGD","LU1066053197.SGD","LU2112291526.USD","LU0859254822.USD","LU0965508806.USD","TBXU","LU1778281490.HKD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749900","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749900","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749900?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:34","pubTimestamp":1790973240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slipped 1.04% to $403.04 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.73% to 7,722.72 and the Dow Jones Industrial Average  rising 0.49% to 51,176.96.This was the stock's third consecutive day of losses.Amgen Inc. closed 9.84% short of its 52-week high of $447.03, which the company achieved on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.02% to $256.03, Pfizer Inc.  fell 1.14% to $27.80, and AbbVie Inc.  rose 1.11% to $262.82.Trading volume  eclipsed its 50-day average volume of 2.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","TBXU","LU2468319806.SGD","IE00BJT1NW94.SGD","PBE","LU1057294990.SGD","LU2089984988.USD","LU2242652126.USD","LU1061106388.HKD","LU1571399168.USD","IE0009355771.USD","BK4599","LU0868494617.USD","BK4533","BK4585","AMGN","BK4139","IE00BFTCPJ56.SGD","IBBQ","BIB","LU2112291526.USD","LU0289739699.SGD","LU0889565916.HKD","LU0122379950.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","PJP","BK4534","IBB","LU0058720904.USD","LU2242646821.SGD","BK4588","04332","BK4581","BBH","BK4566","IE0002141913.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","SG9999001440.SGD","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672034743","title":"Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2672034743","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672034743?lang=en_us&edition=fundamental","pubTime":"2026-10-03 01:05","pubTimestamp":1790960723,"startTime":"0","endTime":"0","summary":"Legend Biotech's (LEGN) multiple myeloma therapy Carvykti is facing growing competitive pressure as Gilead Sciences' (GILD) anito-cel approaches a potential approval and Johnson & Johnson's (JNJ) Tec-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBBQ","IE00B42XCP33.USD","BK4504","JNJ","LU0545039389.USD","MEDI","GDOC","BIB","LU1162221912.USD","LU0320765992.SGD","IE00BLSP4452.SGD","VHT","BMED","FHLC","LU1585245621.USD","LU0345769631.USD","BK4550","LABU","LU0859254822.USD","PJP","XBI","LU0345770308.USD","TRUH","FTXH","LU0889566641.SGD","TMED","XLV","IBB","IE0034235303.USD","TBXU","MEDX","GILD","IHE","JDOC","CANC","LU1261432733.SGD","LU1221951046.USD","MEMS","IYH","IE00BLSP4239.USD","LEGN","IXJ","BBH","LU0426417589.USD","SG9999001440.SGD","IE00BKVL7J92.USD","LU1057294990.SGD","RXL","LU0545562505.USD","LU2129689605.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672174313","title":"Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise","url":"https://stock-news.laohu8.com/highlight/detail?id=2672174313","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672174313?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:30","pubTimestamp":1790958636,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s AMGN Evolocumab Study Highlights Subtle Edge in Cholesterol Drug Del...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-evolocumab-study-signals-quiet-efficiency-gains-for-cholesterol-franchise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-evolocumab-study-signals-quiet-efficiency-gains-for-cholesterol-franchise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2242646821.SGD","LU1983299246.USD","IE00B2B36J28.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","AMGN","LU0058720904.USD","IE00BJT1NW94.SGD","BK4139","BK4599","IE0009355771.USD","LU2468319806.SGD","PJP","BBH","IBBQ","BK4534","LU0320765992.SGD","BK4581","LU0868494617.USD","LU1057294990.SGD","LU0122379950.USD","BIB","LU2242652126.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","BK4533","IE00BJJMRZ35.SGD","BK4585","LU0289739699.SGD","BK4588","LU2112291526.USD","IE0002141913.USD","BK4566","LU2089984988.USD","IBB","LU1023059063.AUD","TBXU","SG9999001440.SGD","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672714416","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672714416","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672714416?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:30","pubTimestamp":1790944215,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on TransMedics Group (TMDX), Regeneron (REGN) and Tar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-transmedics-group-tmdx-regeneron-regn-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-transmedics-group-tmdx-regeneron-regn-and-tarsus-pharmaceuticals-tars-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU2324357040.USD","BK4585","LU0289739699.SGD","LU2362540622.SGD","LU2362541513.USD","LU0109394709.USD","LU2065731478.USD","LU0889565916.HKD","LU2237438978.USD","LU0823416689.USD","LU2468319806.SGD","BBH","BK4588","LU2362541273.HKD","XBI","LU2023250504.SGD","BK4581","LABU","LU0823434583.USD","LU1917777945.USD","HCSG","LU0823434740.USD","TARS","TBXU","LU1974910355.USD","LU0053666078.USD","IBBQ","LU2106854487.HKD","LU0029874061.USD","LU0128526141.USD","BK4082","LU0058720904.USD","REGN","BK4137","BK4139","TMDX","LU0882574055.USD","XLV","IBB","LU2089984988.USD","LU0114720955.EUR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672071900","title":"Piper Sandler Remains a Buy on Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672071900","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672071900?lang=en_us&edition=fundamental","pubTime":"2026-10-02 19:35","pubTimestamp":1790940929,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Biren Amin maintained a Buy rating on Regeneron today and set a price target of $854.00. Amin covers the Healthcare sector, f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","LU2468319806.SGD","LU2023250504.SGD","LU2324357040.USD","REGN","LU0053666078.USD","LU0889565916.HKD","LU0114720955.EUR","LU1917777945.USD","LU1974910355.USD","BK4588","BK4581","LU2362541513.USD","IBBQ","LU2237438978.USD","LU0823434583.USD","LU2362540622.SGD","LU0320765992.SGD","LU0058720904.USD","XLV","XBI","BK4139","LU2362541273.HKD","LU0109394709.USD","LABU","BBH","LU0882574055.USD","LU0823416689.USD","LU0823434740.USD","LU2106854487.HKD","LU0289739699.SGD","BK4585","IBB","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715686","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715686","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715686?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:50","pubTimestamp":1790934645,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsOct 2 (Reuters)-Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Swiss drugmaker NovartisNOVN.Sto develop an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","SG9999014880.SGD","IE00BFXG1179.USD","KURE","BK1587","LU2023250504.SGD","LU2293690249.USD","IE00B1BXHZ80.USD","LU0827474353.SGD","SG9999015945.SGD","LU0784383803.USD","LU1366192091.USD","LU0124676726.USD","LU1481599808.USD","IE00B19Z3581.USD","LU0320765646.SGD","IE00B3PB1722.GBP","LU2750360997.AUD","BK4551","LU0390134368.USD","LU1035775433.USD","LU1487256676.USD","LU0661504455.SGD","LU0348827113.USD","LU1280957306.USD","LU1267930227.SGD","LU2361044949.HKD","LU2399975544.HKD","LU0057025933.USD","LU0106261372.USD","LU0306806265.USD","LU2125909593.SGD","LU1670628061.USD","IE00B543WZ88.USD","BK0239","MHIP","LU0501845795.SGD","LU2433249047.HKD","BK4592","LU2488822045.USD","HCM","LU1883839398.USD","LU0348784397.USD","LU0353189680.USD","LU0965508806.USD","IE0005OL40V9.USD","LU0887340254.USD","LU0203345920.USD","LU0321505439.SGD","ILDR","LU1732799900.SGD","LU1302929846.USD","LU0820561818.USD","LU0203201768.USD","LU0889566641.SGD","600276","LU0348825331.USD","LU1051770623.HKD","LU1496350171.SGD","SG9999014559.SGD","LU2097828557.USD","BK0196","LU0969580561.USD","LU0417516738.SGD","LU1496350502.SGD","LU2168564495.EUR","IXJ","VHT","LU0526926950.USD","LU0244354667.USD","01093","LU0079474960.USD","LU1328277881.USD","LU2462157665.USD","LU0354030438.USD","LU1188198961.HKD","IE00B42XCP33.USD","LU0882574139.USD","LU2097828474.EUR","SGXZ31699556.SGD","LU1781817850.SGD","IE00BLSP4239.USD","LU0708994859.HKD","LU1934455277.USD","BK4568","LU2539964713.USD","LU1718418525.SGD","LU0889565916.HKD","LU0128525929.USD","LU1997245094.SGD","IE00BKDWB100.SGD","LU0964806797.USD","LU2360032135.SGD","NVOH","IE0008369823.USD","NVO","IYH","LU1226287529.USD","LU2108987350.USD","LU0211331839.USD","LU0011850046.USD","LU1868836591.USD","LU2289578879.USD","NVOX","SG9999002232.USD","IE00BZ1G4Q59.USD","LU1153584641.USD","LU0943347566.SGD","SG9999001440.SGD","SG9999001176.USD","LU0289961442.SGD","LU0047473722.SGD","LU1969619763.USD","IE00BDGV0183.EUR","LU2324357040.USD","IE00B031HY20.USD","IE00BK4W5M84.HKD","LU2168564222.USD","ELIL","LU1064131003.USD","IHE","LU0211326755.USD","LU2495084118.USD","LU0980610538.SGD","LU0353189763.USD","LU1989772840.SGD","LU1839511570.USD","LU0345777659.USD","HRTS","LU0964807845.USD","LU0640478417.SGD","LU0225284248.USD","LU2063271972.USD","IE00B2B36J28.USD","LU0965509283.SGD","LU2091194634.USD","LU2552382058.USD","LU1551013425.SGD","IE00BFTCPJ56.SGD","LU2461242641.AUD","SGXZ57979304.SGD","IE0002141913.USD","BK4559","LU0053666078.USD","LU2646069778.SGD","IBBQ","LU0823434740.USD","LU1670627923.USD","LU2756315318.SGD","LU2028103732.USD","LU1960683339.HKD","LU2125154778.USD","BK1589","BK1588","LU0348767384.USD","LU0061475181.USD","IE00BKPKM643.USD","LU1003076772.USD","BK4578","LU0784385840.USD","LU0114720955.EUR","LU0405327148.USD","LU0234570918.USD","LU0784385170.HKD","LU1226288253.USD","IE0008368742.USD","LU0256863811.USD","LU0949170772.SGD","BK0028","PPH","GLAM","LU2355687059.USD","LU1894683264.USD","LU1988902786.USD","SG9999015358.SGD","LU0472753341.HKD","LU1032466523.USD","IE000BZT7R73.USD","LU1145028129.USD","LU2097828805.USD","LU0976567544.SGD","LU2491049909.HKD","LU1670711040.USD","SG9999015986.USD","LU1046234339.USD","688331","LU0502904849.HKD","LU0405327494.USD","LU1868836914.USD","LU0171276677.USD","LU1236620750.USD","LU0634319403.HKD","LU1997244956.HKD","SG9999011175.SGD","LU2129689605.HKD","IE00BJT1NW94.SGD","LU0348766576.USD","LU0432979614.USD","LU1400636574.HKD","LU1228905540.USD","LU1309081286.SGD","REGN","MEDI","BK4585","IE00BLSP4452.SGD","LU2125909247.SGD","LU2242646821.SGD","SG9999017495.SGD","LU0237698245.USD","IE00BWXC8680.SGD","LU0912757837.SGD","LU1023059063.AUD","LU1153585028.USD","688506","LU1993786604.SGD","LU1894683348.USD","LU0130517989.USD","LU0069063385.USD","IE00B3M56506.USD","LU1228905037.USD","LU1064927863.SGD","LU0345770308.USD","LU1244550221.USD","LU1941712264.USD","LU1655091616.SGD","GSK.UK","LU1355424745.HKD","LU1863844749.USD","TMED","BK5011","BK0183","LU2750360641.GBP","SGXZ51526630.SGD","LU0047473722.EUR","LU0072913022.USD","LU2237443549.SGD","LU0545562505.USD","LU2596442595.SGD","LU2471134879.HKD","LU2293690082.USD","IE0002270589.USD","LU0162691827.USD","IE00BZ08YS42.EUR","LU0354030511.USD","LU0154236417.USD","LU0267386448.USD","LU1863844665.USD","LU0757432116.USD","LU2089283258.USD","LU2357627491.SGD","LU0067412154.USD","LU0965509101.SGD","LU1580142542.USD","LLY","LU0795875086.SGD","LU1868837300.USD","IE00BWDBJ516.SGD","LU1623119135.USD","IE00BK4W5L77.USD","LU1226287875.USD","LU0320765992.SGD","LU0456855351.SGD","LU2362540622.SGD","SG9999014906.USD","AGNG","LU0972486137.USD","LU1003077747.HKD","LU1481600234.SGD","MRK","LU0070302665.USD","CURE","LU1069347547.HKD","LU1255011170.USD","LU0861579265.USD","LU0640476718.USD","LU0557290698.USD","LU3187612489.SGD","LU2129689514.USD","LU1923622614.USD","LU1084165304.USD","IE00B4JS1V06.HKD","BNTX","LU2476274308.USD","LU1201861249.SGD","LU2148510915.USD","PJP","XLV","LU0256863902.USD","LU2242652126.USD","LU0689472784.USD","LU1720051108.HKD","LU1244550577.SGD","LU0868494617.USD","SG9999015952.SGD","LU2097828631.EUR","LU2237443382.USD","LU1291159041.SGD","LU0942090050.USD","LU2111349929.HKD","IE00BBT3K403.USD","LU0310800379.SGD","LU2023250843.SGD","LU1267930490.SGD","LU0345777147.USD","LU1699723380.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","SG9999003800.SGD","LU2746668974.SGD","LU0316494557.USD","LU2039709279.SGD","SG9999018865.SGD","03692","IE000M9KFDE8.USD","LU2089984988.USD","LU0098860793.USD","LU0133085943.USD","ABBV","LU1941712348.USD","LU1983299246.USD","LU1273509221.SGD","BK4139","LU1670711123.USD","RHHBY","BK4535","LU1116320901.HKD","LU2756315664.SGD","LU0266013472.USD","SG9999001176.SGD","LU2362541513.USD","LU1037948897.HKD","LU2456880835.USD","LU2087625088.SGD","BK1515","LU2129689431.USD","LU1152091754.HKD","LU0161305163.EUR","LU0130102774.USD","IE000WAW04H5.SGD","LU0052756011.USD","LU1820825898.SGD","LU0499090636.EUR","SG9999014567.USD","FTXH","LU0265550946.USD","LU0171293334.USD","LLII","LU2476274720.SGD","LU0868494708.USD","BK1521","LU1548497426.USD","LU1880407215.USD","LU2471134796.USD","SGXZ99366536.SGD","BK4533","LU2211815571.USD","RXL","LU2552382215.SGD","LU1629891620.HKD","IE00BKPKM429.USD","LU1712237335.SGD","LU1814569148.SGD","SG9999004220.SGD","LU1008478684.HKD","LU1116320737.USD","TRUH","IE00BFSS7M15.SGD","LU1226287792.SGD","MEDX","LU2328871848.SGD","LU1267930813.SGD","LU1104425308.USD","LU0417517546.SGD","LU0203347892.USD","LU0077335932.USD","IE00BZ08YT58.USD","LU0210536198.USD","LU0238689110.USD","LU1261432733.SGD","LU0385154629.USD","LU0882574055.USD","LU1934455194.USD","IE0009355771.USD","LU0820561909.HKD","BK1593","BK4566","LU2133065610.SGD","LU2746668461.USD","LU0158827781.USD","LU2491050154.USD","HK0000165453.HKD","LU1585245621.USD","LU1098665638.USD","IE0000B7K699.USD","LU1670710588.SGD","IE00B7KXQ091.USD","LU0889565080.SGD","LU2023250330.USD","01276","LU0820562030.AUD","LU2097828714.EUR","LU0029864427.USD","LU2279689827.SGD","LU1831875114.USD","BK1161","LU0058720904.USD","LU1035773651.USD","LU1064130708.USD","LU0225771236.USD","LU0471298694.HKD","LU0553294199.USD","LU0607220059.USD","BK1574","IE00BGHQF631.EUR","LU0466842654.USD","LU0211328371.USD","SG9999002224.SGD","LU2242644610.SGD","SG9999014575.USD","LU0823434583.USD","LU0672654240.SGD","LU2347655073.USD","AZN.UK","LU2023251221.USD","LU2168564065.EUR","LU0128525689.USD","LU1328615791.USD","LU0289739699.SGD","LU2357305700.SGD","LU2360106947.USD","IE0004445239.USD","LU0109391861.USD","LU1226288170.HKD","LU0198837287.USD","LU0823399737.USD","LU1267930730.SGD","IE0001KFT4U8.USD","IE00BJJMRZ35.SGD","LLYZ","PFE","LU0648001328.SGD","LU0997586432.USD","LU1400636657.SGD","LU0314109678.HKD","LU2087621335.USD","GDOC","LU0708995401.HKD","LU1400636491.USD","01530","LU2271345857.HKD","LU0158827948.USD","LU0149534421.HKD","LU0315179316.USD","LU0985320562.USD","LU1232071149.USD","BK0188","LU1720051017.SGD","LU2106854487.HKD","LU1794554557.SGD","LU0072461881.USD","LU0987226296.USD","LU1974910355.USD","BK4588","LU1152091168.USD","LU0211326839.USD","LU1807302812.USD","LU1037948541.HKD","LU0957799991.USD","BK0060","LU0786609619.USD","LU1934455863.HKD","LU0348783233.USD","LU0140636845.USD","LU1035777561.USD","LU0006306889.USD","LU0265550359.USD","LU1691799644.USD","LU1829250122.USD","IE00BZ08YR35.GBP","IE00BJLML261.HKD","LU2347655156.SGD","LU2168563687.JPY","ELIS","LU0857590862.USD","LU1551013342.USD","LU0540923850.HKD","LU0792757196.USD","LU1093756325.SGD","LU2168564149.EUR","LU0880133367.SGD","LU1127390331.HKD","IE000SO60NU8.SGD","LU0738911758.USD","IE0004445015.USD","LU1066051225.USD","LU0575583348.USD","LU1301847155.USD","LU2237443465.HKD","LLYX","IE00BFSS8Q28.SGD","LU1202635105.USD","LU1066051498.USD","LU2114397693.USD","LU1146622755.USD","LU0094547139.USD","LU0920783379.SGD","IE00BKVL7J92.USD","LU0174119429.USD","LU1917777945.USD","LU0463099449.HKD","LU2264538146.SGD","LU2237443622.USD","LU1720050803.USD","LU2361045086.USD","LU0455707207.USD","BK4516","LU0289739343.SGD","LU0096364046.USD","LU1670756490.USD","LU0545039389.USD","IE000MB6IJN5.SGD","LU0097036916.USD","LU1323610961.USD","LU0225283273.USD","09995","LU0109981661.USD","LU0170899867.USD","BK4007","LU1078025761.USD","SG9999018857.SGD","LU1069344957.HKD","LU2236285917.USD","LU0960981461.USD","LU0949170426.SGD","LU2468319806.SGD","IE00B5MMRT66.SGD","IE00BVYPNW00.USD","LU1019632923.USD","LU1066053197.SGD","LU1015430645.USD","IE00BQJZX424.USD","01801","LU1066051811.HKD","WDNA","LU1868837136.USD","IBB","IE000F7OJYX1.SGD","CANC","BK1191","OZEM","LU1645745479.HKD","LU0471298777.SGD","LU2778985437.USD","LU1929549753.HKD","LU1430594728.SGD","THNR","IE00BN8TJ469.HKD","LU1989771016.USD","LU0920840948.USD","BK4550","LU1061106388.HKD","LU1997245177.USD","IE00B19Z3B42.SGD","SG9999013999.USD","LU1074936037.SGD","SGXZ81514606.USD","03933","LU0310799852.SGD","LU0965509010.AUD","LU1236620834.HKD","LU0234572021.USD","LU0689626769.HKD","LU0208291251.USD","NVOC","BK4534","LU0395794307.EUR","LU0417516902.SGD","LU1244550494.USD","BBH","LU0320765489.SGD","LU1732800096.USD","SG9999014898.SGD","LU2112291526.USD","LU1813983027.USD","LU1119994496.HKD","LU1046248800.SGD","LU1162221912.USD","LU0823416689.USD","LU1196032939.SGD","LU1093756168.USD","LU0787776722.HKD","LU1019634622.SGD","02096","GB00BDT5M118.USD","IE00BVYPNV92.GBP","LU0971552830.HKD","LU0795875169.SGD","LU0971552673.USD","LU0211327993.USD","LU0496365809.HKD","SG9999015978.USD","BK0012","LU1064131342.USD","LU2580892862.HKD","IE00B3T34201.USD","LU1880407132.USD","SG9999014542.SGD","03165","LU1989772923.USD","BK4532","LU2265009873.SGD","PAWZ","LU0511384066.AUD","IE00B775H168.HKD","BMED","BK1583","LU2602419157.SGD","IE00BJJMRX11.SGD","LU2580892789.USD","LU0683600562.USD","SG9999014914.USD","BK4599","IE00B1XK9C88.USD","IE00BPRC5H50.USD","SG9999015341.SGD","LU2237443978.SGD","LU0985481810.HKD","LU2471134523.USD","BMY","LU0417516571.SGD","LU0326950275.SGD","LU2417539215.USD","LU2462591350.SGD","LU2361044865.SGD","LU1170363599.USD","LU0561508036.HKD","LU1868836757.USD","LU1670710661.SGD","SMMT","LU0963555726.SGD","00013","LU2896262040.SGD","LU1961090484.USD","LU1979441026.SGD","LU0997586515.USD","LU2237438978.USD","LU1804176565.USD","IE00BN29S564.USD","IE0034235071.USD","LU0203202063.USD","LU0323591593.USD","LU0784384876.USD","LU2089284900.SGD","LU2237443895.HKD","BK4548","LU1571399168.USD","LU0321505868.SGD","NVS","LU0306807586.USD","IE00BSNM7G36.USD","09926","LU2213496289.HKD","LU1951186391.HKD","LU2471134952.CNY","LU0477156953.USD","BK4581","LU0726765562.USD","FHLC","LU0348735423.USD","TBXU","IE0034235188.USD","LU0345770993.USD","LU0310800965.SGD","JDOC","LU2125154935.USD","LU0859254822.USD","LU2362541273.HKD","LU2491050071.SGD","LU2552382132.HKD","LU0122379950.USD","LU1267930573.SGD","IE00BJJMRY28.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672137097","title":"Sanofi, Regeneron's Dupixent Successors Might Fall Short of Rivals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672137097","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672137097?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:35","pubTimestamp":1790933700,"startTime":"0","endTime":"0","summary":"0934 GMT - Sanofi and Regeneron Pharmaceuticals' potential successors to blockbuster medicine Dupixent might lag behind rival drugs Pfizer and AbbVie are developing, Citi analysts say in a research note. The new experimental drugs Sanofi and Regeneron will jointly develop under their alliance focus solely on extending the dosing interval of Dupixent without compromising efficacy or tolerability, but there is no expectation of a superior performance, Citi says. This suggests those medicines might struggle to compete with Pfizer's tilrekimig and AbbVie's zumilokibart, both of which have shown potential for better efficacy in midstage trials, according to Citi. Moreover, it might be challenging for Sanofi and Regeneron to get reimbursement for those drugs from healthcare payers after copycat versions of Dupixent become available, the analysts add. Sanofi shares fall 3.4%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU0211327993.USD","LU2106854487.HKD","LU0965509283.SGD","ABBV","JDOC","LU1037948541.HKD","IXJ","TBXU","PJP","LU0098860793.USD","LU0795875169.SGD","IBBQ","LU0949170772.SGD","VHT","LU2112291526.USD","XLV","LU0158827948.USD","LU1244550577.SGD","SNY","FTXH","GLAM","SNYNF","LU0069063385.USD","LU0057025933.USD","MEDX","LU1720051108.HKD","AGNG","BBH","FHLC","TRUH","LU1883839398.USD","BK4585","LU0417517546.SGD","IE00BJT1NW94.SGD","REGN","OZEM","LU0128525929.USD","LU2347655073.USD","BK4599","IBB","LU1917777945.USD","IYH","LU0029864427.USD","LU0203347892.USD","PPH","PFE","LU2133065610.SGD","RXL","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672713007","title":"Analysts’ Top Healthcare Picks: Regeneron (REGN), Idexx Laboratories (IDXX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672713007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672713007?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:20","pubTimestamp":1790932825,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Regeneron (REGN) and Idexx Laboratories (IDXX) with ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-regeneron-regn-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-regeneron-regn-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BK4082","GB00B4LPDJ14.GBP","LU0690374615.EUR","GB00B4QBRK32.GBP","LU0170899867.USD","BK4581","LU0345774391.USD","LU1941712264.USD","LU2362540622.SGD","LU0823434583.USD","TBXU","BK4567","LU1974910355.USD","PAWZ","BK4137","LU2468319806.SGD","XBI","LU0029874061.USD","LU0320765992.SGD","LU1917777945.USD","LU2404859741.USD","LU2362541273.HKD","LU2106854487.HKD","LU2237438978.USD","IBBQ","LU0289739699.SGD","LU0823434740.USD","LU0114720955.EUR","XLV","LU0823416689.USD","LU0128526141.USD","BK4139","BK4504","LABU","LU2023250504.SGD","LU0345774631.USD","LU2404859667.USD","LU1989771016.USD","IBB","BBH","LU0882574055.USD","LU0053666078.USD","BK4588","HCSG","REGN","LU1941712348.USD","LU2324357040.USD","LU2089984988.USD","IDXX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672713165","title":"Vertex Minerals lodges 2026 corporate governance statement with ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2672713165","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672713165?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:08","pubTimestamp":1790932081,"startTime":"0","endTime":"0","summary":"The latest update is out from Vertex Minerals Ltd. ( ($AU:VTX) ). Vertex Minerals Ltd. has lodged its Appendix 4G and 2026 Corporate Governance Sta...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-lodges-2026-corporate-governance-statement-with-asx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-lodges-2026-corporate-governance-statement-with-asx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CDEI","SG9999013999.USD","EXEQ","VRTX","TBXU","LU0432979614.USD","CVLC","IE00B4R5TH58.HKD","GNMX","DSI","LU0256863811.USD","IE00B19Z3B42.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD","SGXZ57979304.SGD","ESGA","IBBQ","FDRX","ESML","PBE","LU1035775433.USD","HAPI","IE00B2B36J28.USD","BK4567","BIB","VERX","NUSC","BBH","IDNA","ESGV","SSPX","BK4585","JSTC","LU1778281490.HKD","BK4139","NUDV","SUSA","MDCP","PEMX","ESGY","CHRI","ESG","LOPP","VOTE","SG9999001176.USD","IBB","IE0002270589.USD","MTX","HAPY","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672718956","title":"Sino Biopharmaceutical Stock Falls 2.3% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672718956","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672718956?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:33","pubTimestamp":1790929980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slid 2.3% to 5.58 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 2.6% to 23972.29.The stock's fall snapped a two-day winning streak.Sino Biopharmaceutical Ltd. closed 35% short of its 52-week high of HK$8.54, which the company achieved Oct. 8.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 1.4% and Amgen Inc. remained unchanged.Trading volume totaled 35.3 million shares, compared to the 50-day average of 80.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IE0002141913.USD","LU1057294990.SGD","LU0889565916.HKD","BK1521","TBXU","IE00BZ08YT58.USD","BK4588","SG9999001440.SGD","LU1983299246.USD","LU0868494617.USD","PJP","PBE","IE00BZ08YS42.EUR","HK0000165453.HKD","BK4139","IE00BFTCPJ56.SGD","LU2112291526.USD","IE00BJT1NW94.SGD","BK4566","91335","LU0122379950.USD","BK4533","LU1061106388.HKD","IBB","BK1515","LU1023059063.AUD","LU2089984988.USD","BIB","AMGN","LU0058720904.USD","BK4534","BK4581","LU0320765992.SGD","IBBQ","01177","IE00BZ08YR35.GBP","LU2242646821.SGD","LU2468319806.SGD","LU1571399168.USD","IE0009355771.USD","LU0289739699.SGD","BK4585","BK4599","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0109394709.USD","IE00BJJMRZ35.SGD","LU2242652126.USD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166541763","title":"Hong Kong Stock Movers: Innovative Drug Stocks Retreat, InnoCare Pharma (09969) Falls Over 8%, RemeGen (09995) Drops Nearly 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166541763","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166541763?lang=en_us&edition=fundamental","pubTime":"2026-10-02 15:52","pubTimestamp":1790927535,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks broadly retreated, with InnoCare Pharma (09969) falling 8.38% to HK$13.55, RemeGen (09995) dropping 5.71% to HK$72.7, and 3SBio (01530) declining 4.95% to HK$15.75 as...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BK1593","HK0000165453.HKD","09969","VXUS","06978","688331","LU1969619763.USD","LU2328871848.SGD","LNGR","BK0239","688428","BK4588","LU2488822045.USD","BK1574","01530","09995","BK1583","LU2148510915.USD","KCAI","IBBQ","BK1161","LU1064130708.USD","BK4585","159992","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}